Target intelligence / Profile preview

Interferon receptor (IFNAR (for type I), IFNGR (for type II))

Target
IFNAR (for type I), IFNGR (for type II)
Molecular classification
Receptor, Cytokine receptor family, Transmembrane protein
01

Overview

The interferon receptors are a family of cell-surface receptors that mediate the effects of interferons—potent cytokines central to antiviral defense and immune modulation. There are two main classes relevant to human immunity: Type I interferon receptors consist primarily of the heterodimeric complex formed by IFNAR1 and IFNAR2, which bind all type I interferons including multiple subtypes such as IFN-alpha and IFN-beta. Upon ligand binding, these receptors activate associated Janus kinases (JAK1, TYK2) that phosphorylate signal transducers (STAT1, STAT2) leading to the formation and nuclear translocation of the ISGF3 transcriptional complex. This results in upregulation or repression of hundreds of genes involved in antiviral responses, apoptosis regulation, cell proliferation control, and immunomodulation. The pathway also cross-talks with MAPK and PI3K-Akt signaling cascades for broader cellular effects[1][2][5]. Type II interferon receptors comprise a different heterodimeric structure (IFNGR1/CD119 plus IFNGR2) specific for binding interferon gamma (IFNG). Ligand engagement activates JAK1/JAK2 kinases resulting mainly in phosphorylation/homodimerization/nuclear importation by STAT1; this drives expression from GAS elements on target gene promoters—key for macrophage activation, antigen presentation enhancement, Th1 differentiation support, NK cell activity boosting—and can have both anti-tumorigenic/cytostatic as well as context-dependent pro-tumorigenic effects[4]. Both types play essential roles in host defense against pathogens but can be dysregulated in autoimmunity or cancer.

Other names
Type I interferon receptorType II interferon receptorIFN-alpha/beta receptorIFN-gamma receptorIFNAR1/2IFNGR1/2
02

Mechanism of action

Activation of JAK/STAT signaling pathway upon ligand binding[2][3][5][7] - Induction of ISGF3 complex formation and nuclear translocation for gene expression regulation - Phosphorylation and dimerization of STAT proteins leading to transcriptional activation or repression of immune genes

03

Biological functions

Immune responseSignal transductionAntiviral defenseRegulation of cell growth and apoptosisModulation of inflammation
04

Disease associations

Infection (especially viral)CancerInflammationAutoimmune disease
05

Safety considerations

Risk for excessive immune activation ("cytokine storm")Autoimmunity induction with chronic stimulationFlu-like symptoms with therapeutic use
06

Interacting drugs

Interferon alpha (IFN-alpha)

2 more in the full profile.

07

Biomarkers

Phosphorylated STAT1 or STAT2 levels in cells after stimulationExpression levels of interferon-stimulated genes such as ISG15, PML, or MX1

Beyond the preview

Go deeper on Interferon receptor (IFNAR (for type I), IFNGR (for type II)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon receptor (IFNAR (for type I), IFNGR (for type II)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call